Correcting dilated cardiomyopathy with fibroblast-targeted p38 deficiency
Ross C. Bretherton(California Institute for Regenerative Medicine), Jennifer Davis(Cincinnati Children's Hospital Medical Center), Franziska Koser(University Hospital Münster), Jagdambika Gunaje(University of Washington), Cole A. DeForest(University of Washington), Alex J. Goldstein(University of Washington), Farid Moussavi‐Harami(California Institute for Regenerative Medicine), Kristin A. Zabrecky(University of Washington), Amy Martinson(University of Washington), Kristina B. Kooiker(California Institute for Regenerative Medicine), Timothy S. McMillen(Anna Needs Neuroblastoma Answers), Galina Flint(Mahindra and Mahindra Limited (India)), Wolfgang A. Linke(University Hospital Münster), Nathan J. Sniadecki(University of Washington), Michael Regnier(University of Washington), Isabella M. Reichardt(University of Washington), Darrian Bugg(University of Washington), Elizabeth Plaster(University of Washington), Logan R.J. Bailey(University of Washington)
Cited by 5
Related Papers
The Translational Landscape of the Human Heart
|Cell|2019|681
Titin mutations in iPS cells define sarcomere insufficiency as a cause of dilated cardiomyopathy
|Science|2015|650
Titin-truncating variants affect heart function in disease cohorts and the general population
|Nature Genetics|2016|367
Gigantic Business
|Circulation Research|2014|327